Search

everythinglearnresearchcommunity

for

Search:↓

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The Rotterdam Study aims to understand various diseases in older adults.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.